Pro: aprotinin should be used in patients undergoing hypothermic circulatory arrest.
Royston
D
D
Department of Anaesthesia, Royal Brompton and Harefield NHS Trust, Harefield Hospital, United Kingdom.
D001011:Aorta / Q000601:surgery; D007611:Aprotinin / Q000009:adverse effects / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control; D006348:Cardiac Surgical Procedures; D006324:Heart Arrest, Induced; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007036:Hypothermia, Induced; D007249:Inflammation / Q000517:prevention & control; D011183:Postoperative Complications / Q000517:prevention & control; D013927:Thrombosis / Q000453:epidemiology
D006490:Hemostatics; D007611:Aprotinin